Investors

Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Our portfolio includes late-stage programs that we are developing to be innovative therapeutics capable of addressing the unmet medical needs of those individuals.

Featured Presentation

WEBCAST

There are currently no events to display.

UPCOMING EVENTS

There are currently no events to display.

Data Provided by Refinitiv. Minimum 15 minutes delayed.